Sinovac Biotech Company Profile (NASDAQ:SVA)

About Sinovac Biotech (NASDAQ:SVA)

Sinovac Biotech logoSinovac Biotech Ltd. (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza and mumps. The Company's pipeline consists of vaccine candidates in the clinical and pre-clinical development Phases in China. The Company is engaged in the sales, marketing, manufacturing and development of vaccines for infectious disease. The Company develops various products, including Healive, Bilive, Anflu, Panflu Whole Viron Pandemic Influenza Vaccine, Split Viron Pandemic Influenza Vaccine, Panflu.1, RabEnd, Mumps Vaccine, Enterovirus 71 (EV71) Vaccine, Pneumococcal Polysaccharide Vaccine, Pneumococcal Conjugate Vaccine, Rubella Vaccine, Varicella Vaccine and Sabin Inactivated Polio Vaccine.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biopharmaceuticals
  • Sub-Industry: N/A
  • Symbol: NASDAQ:SVA
  • CUSIP: N/A
  • Web: www.sinovac.com
Capitalization:
  • Market Cap: $400.84 million
  • Outstanding Shares: 56,968,000
Average Prices:
  • 50 Day Moving Avg: $6.95
  • 200 Day Moving Avg: $6.25
  • 52 Week Range: $4.60 - $7.16
P/E:
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $64.02 million
  • Price / Sales: 6.26
  • Book Value: $2.02 per share
  • Price / Book: 3.48
Profitability:
  • EBITDA: ($837,000.00)
Misc:
  • Average Volume: 80,520 shs.
  • Short Ratio: 1.53
 

Frequently Asked Questions for Sinovac Biotech (NASDAQ:SVA)

What is Sinovac Biotech's stock symbol?

Sinovac Biotech trades on the NASDAQ under the ticker symbol "SVA."

How were Sinovac Biotech's earnings last quarter?

Sinovac Biotech, Ltd. (NASDAQ:SVA) posted its earnings results on Tuesday, August, 23rd. The company reported ($0.15) earnings per share (EPS) for the quarter. The firm had revenue of $1.38 billion for the quarter, compared to the consensus estimate of $18.49 billion. During the same period in the previous year, the company posted $0.02 EPS. View Sinovac Biotech's Earnings History.

Who are some of Sinovac Biotech's key competitors?

Who are Sinovac Biotech's key executives?

Sinovac Biotech's management team includes the folowing people:

  • Weidong Yin, Chairman of the Board, President, Chief Executive Officer, Secretary
  • Nan Wang, Chief Financial Officer
  • Ming Xia, Vice President - Sales and Marketing of Sinovac Beijing
  • Simon J. Anderson, Independent Director
  • Jue Lee, Independent Director
  • Yuk Lam Lo, Independent Director
  • Meng Mei, Independent Director

Who owns Sinovac Biotech stock?

Sinovac Biotech's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Eqis Capital Management Inc. (0.26%). View Institutional Ownership Trends for Sinovac Biotech.

Who sold Sinovac Biotech stock? Who is selling Sinovac Biotech stock?

Sinovac Biotech's stock was sold by a variety of institutional investors in the last quarter, including Eqis Capital Management Inc.. View Insider Buying and Selling for Sinovac Biotech.

How do I buy Sinovac Biotech stock?

Shares of Sinovac Biotech can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Sinovac Biotech's stock price today?

One share of Sinovac Biotech stock can currently be purchased for approximately $7.03.


MarketBeat Community Rating for Sinovac Biotech (NASDAQ SVA)
Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  68 (Vote Outperform)
Underperform Votes:  73 (Vote Underperform)
Total Votes:  141
MarketBeat's community ratings are surveys of what our community members think about Sinovac Biotech and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Sinovac Biotech (NASDAQ:SVA) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A
Consensus Price Target History for Sinovac Biotech (NASDAQ:SVA)
Price Target History for Sinovac Biotech (NASDAQ:SVA)
Analysts' Ratings History for Sinovac Biotech (NASDAQ:SVA)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Sinovac Biotech (NASDAQ:SVA)
Earnings by Quarter for Sinovac Biotech (NASDAQ:SVA)
Earnings History by Quarter for Sinovac Biotech (NASDAQ SVA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/28/2016Q316$0.05$0.06$16.76 million$28.74 millionViewN/AView Earnings Details
8/23/2016Q2($0.15)$18.49 billion$1.38 billionViewListenView Earnings Details
5/26/2016Q116($0.01)$10.95 millionViewN/AView Earnings Details
4/5/2016Q415$0.01$22.95 millionViewN/AView Earnings Details
11/11/2015Q315($0.02)($0.03)$27.10 million$16.80 millionViewListenView Earnings Details
8/12/2015Q215($0.01)$0.04$15.70 million$18.50 millionViewListenView Earnings Details
5/15/2015Q115$0.02($0.04)$12.70 million$9.27 millionViewN/AView Earnings Details
4/20/2015Q414$0.01$0.02$14.10 million$22.90 millionViewN/AView Earnings Details
8/14/2014Q214$0.01($0.04)$17.20 million$12.10 millionViewN/AView Earnings Details
3/19/2014Q4 13($0.01)$0.10$18.75 million$22.90 millionViewN/AView Earnings Details
11/12/2013Q3$0.04ViewListenView Earnings Details
11/15/2012Q312($0.03)($0.06)$12.35 million$14.30 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Sinovac Biotech (NASDAQ:SVA)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Sinovac Biotech (NASDAQ:SVA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Sinovac Biotech (NASDAQ:SVA)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Sinovac Biotech (NASDAQ:SVA)
Latest Headlines for Sinovac Biotech (NASDAQ:SVA)
Source:
Loading headlines, please wait.

Social

Chart

Sinovac Biotech (SVA) Chart for Sunday, October, 22, 2017

This page was last updated on 10/22/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.